Annual Debt To Equity
0.00
0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, RXRX annual debt to equity ratio is 0.00, unchanged on December 31, 2023.
- During the last 3 years, RXRX annual debt to equity has risen by +0.06 (+100.00%).
Performance
RXRX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.05
0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, RXRX quarterly debt to equity ratio is 0.05, unchanged on September 30, 2024.
- Over the past year, RXRX quarterly debt to equity has increased by +0.05 (+100.00%).
- RXRX quarterly debt to equity is now at all-time high.
Performance
RXRX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
RXRX Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | 0.0% | +100.0% |
3 y3 years | +100.0% | +100.0% |
5 y5 years | +100.0% | +100.0% |
RXRX Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | at high | -100.0% |
5 y | 5-year | at high | +100.0% | at high | +183.3% |
alltime | all time | at high | +100.0% | at high | +183.3% |
Recursion Pharmaceuticals Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | 0.05(0.0%) |
Jun 2024 | - | 0.05(>+9900.0%) |
Mar 2024 | - | 0.00(0.0%) |
Dec 2023 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2023 | - | 0.00(0.0%) |
Jun 2023 | - | 0.00(0.0%) |
Mar 2023 | - | 0.00(0.0%) |
Dec 2022 | 0.00 | 0.00(0.0%) |
Sep 2022 | - | 0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | 0.00(0.0%) |
Mar 2022 | - | 0.00(0.0%) |
Dec 2021 | 0.00(-100.0%) | 0.00(0.0%) |
Sep 2021 | - | 0.00(-100.0%) |
Jun 2021 | - | 0.02(-140.0%) |
Mar 2021 | - | -0.05(-16.7%) |
Dec 2020 | -0.06(-40.0%) | - |
Dec 2020 | - | -0.06 |
Dec 2019 | -0.10 | - |
FAQ
- What is Recursion Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual debt to equity year-on-year change?
- What is Recursion Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly debt to equity year-on-year change?
What is Recursion Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of RXRX is 0.00
What is the all time high annual debt to equity for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual debt to equity ratio is 0.00
What is Recursion Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, RXRX annual debt to equity ratio has changed by 0.00 (0.00%)
What is Recursion Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of RXRX is 0.05
What is the all time high quarterly debt to equity for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly debt to equity ratio is 0.05
What is Recursion Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, RXRX quarterly debt to equity ratio has changed by +0.05 (+100.00%)